Atlas Trials

Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma

Clinical trial NCT01042704 · COMPLETED

Trial details

NCT number
NCT01042704
Sponsor
Robert Redner, MD
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Myeloma
Start date
2008-02-01
Primary completion
2011-01-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.